Table 1 Antibodies used in this study
Antibody | Dilution | Pretreatment | Source |
|---|---|---|---|
CK7 | 1: 200 | EDTA9.0 | Zhong Shan, Beijing, China |
CDX-2 | 1: 200 | EDTA9.0 | Zhong Shan, Beijing, China |
SATB2 | Universal | EDTA9.0 | Zhong Shan, Beijing, China |
Her2 | Universal | EDTA9.0 | Roche Diagnostics, Basel, Switzerland |
Ki67 | 1: 400 | EDTA9.0 | Zhong Shan, Beijing, China |
MLH1 | Universal | EDTA9.0 | Dako Denmark A/S, Denmark |
MSH2 | Universal | EDTA9.0 | Dako Denmark A/S, Denmark |
MSH6 | Universal | EDTA9.0 | Dako Denmark A/S, Denmark |
PMS2 | Universal | EDTA9.0 | Dako Denmark A/S, Denmark |
Villin | Universal | EDTA9.0 | Zhong Shan, Beijing, China |
CK20 | Universal | EDTA9.0 | Zhong Shan, Beijing, China |
ER | Universal | EDTA9.0 | Roche Diagnostics, Basel, Switzerland |
PAX8 | Universal | EDTA9.0 | Zhong Shan, Beijing, China |
ERCC1 | 1: 200 | EDTA9.0 | Zhong Shan, Beijing, China |
PR | Universal | EDTA9.0 | Roche Diagnostics, Basel, Switzerland |
P53 | 1: 200 | EDTA9.0 | Zhong Shan, Beijing, China |
P16 | 1: 200 | EDTA9.0 | Zhong Shan, Beijing, China |
WT1 | 1: 100 | EDTA9.0 | Mai Xin, Fuzhou, China |
CD31 | 1: 200 | EDTA9.0 | Dako Denmark A/S, Denmark |
D2-40 | 1: 200 | EDTA9.0 | Dako Denmark A/S, Denmark |